The independent source for health policy research, polling, and news.
May 24, 2017
In this May 2017 post, Karen Pollitz and co-author Kathy L. Hudson discuss how H.R. 1313, the Preserving Employee Wellness Programs Act, could substantially change current legal protections for the collection and treatment of genetic information and other personal health information under workplace wellness programs. The post is now available from the New England Journal of Medicine.
Read PostMay 15, 2017
With Medicaid about to be a focal point of debate in the Senate, Drew Altman’s Axios column looks at why the idea that the program is broken is more urban legend than fact.
Column Read PostMay 2, 2017
In this Axios column, Drew Altman analyzes new poll findings which show how one issue breaks through the gridlock between Democrats and Republicans in health – the high cost of prescription drugs.
Column Read PostApril 20, 2017
In this column as an Axios contributor, Drew Altman discusses President Trump’s threat to withhold cost sharing subsidies and questions whether his approach to deal making can bridge health care’s partisan and ideological divide. “Health policy is not like real estate,” he says.
Column Read PostApril 17, 2017
In this April 2017 post, Larry Levitt discusses the current status of the Affordable Care Act’s health insurance marketplaces, and explains how the Trump administration’s choices — including whether to continue cost-sharing reduction payments to insurers — could influence stability of the marketplaces going forward. The post is now available at The JAMA Forum.
Column Read PostApril 7, 2017
In this column for Axios, Drew Altman sees a warning for the Trump administration and Republicans in the latest Kaiser Tracking Poll: the more they do to undermine the Affordable Care Act marketplaces the more the public is likely to hold them, and not the Democrats, accountable for the problems with the law.
Column Read Post